Some patients who appear to recover from COVID-19 after taking Pfizer’s antiviral, Paxlovid, experience a relapse in symptoms soon after — the latest phenomenon researchers and physicians are racing to understand, The Wall Street Journal reported May 10.
Read the full post on Becker's Hospital Review - Healthcare News
